About Solvonis Therapeutics
Solvonis Therapeutics is a company based in London (United Kingdom) founded in 2017 by Victor Bolduev and Anthony Tennyson.. Solvonis Therapeutics has completed 1 acquisition, including AWAKN. Solvonis Therapeutics offers products and services including Novel Medicines and AI-Supported CNS Programmes.
- Headquarter London, United Kingdom
- Founders Victor Bolduev, Anthony Tennyson
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Solvonis Therapeutics Plc
-
Annual Revenue
$0 (USD)-100as on Dec 31, 2024
-
Net Profit
$-1.99 M (USD)49.04as on Dec 31, 2024
-
EBITDA
$-1.89 M (USD)25.75as on Dec 31, 2024
-
Latest Funding Round
$1.67 M (USD), Post-IPO
Oct 16, 2025
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Solvonis Therapeutics
Solvonis Therapeutics is a publicly listed company on the LSE with ticker symbol SVNS in UK, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Solvonis Therapeutics
Solvonis Therapeutics offers a comprehensive portfolio of products and services, including Novel Medicines and AI-Supported CNS Programmes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medicines for addiction and mental health disorders are developed to address treatment limitations.
AI-supported programmes for CNS compounds are utilized in the discovery of new therapeutics.
Funding Insights of Solvonis Therapeutics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $1.7M
-
First Round
First Round
(11 Jul 2025)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - Solvonis Therapeutics | Valuation |
investors |
|
| Jul, 2025 | Amount | Post-IPO - Solvonis Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Solvonis Therapeutics
Solvonis Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AWAKN. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRO focused on early stage clinical trial research
|
2020 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Solvonis Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Solvonis Therapeutics Comparisons
Competitors of Solvonis Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Solvonis Therapeutics
Frequently Asked Questions about Solvonis Therapeutics
When was Solvonis Therapeutics founded?
Solvonis Therapeutics was founded in 2017 and raised its 1st funding round 8 years after it was founded.
Where is Solvonis Therapeutics located?
Solvonis Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Solvonis Therapeutics?
Anthony Tennyson is the current CEO of Solvonis Therapeutics. They have also founded this company.
What does Solvonis Therapeutics do?
Solvonis Therapeutics was founded in 2017 in London, United Kingdom. Operations center on the biotechnology sector, where new medicines are developed to treat addiction and mental health disorders. Initial efforts are directed toward post-traumatic stress disorder, addressing gaps in current treatments. Patient outcomes are targeted for improvement, alongside reductions in associated societal and economic impacts. The companys domain is solvonis.com.
What products or services does Solvonis Therapeutics offer?
Solvonis Therapeutics offers Novel Medicines and AI-Supported CNS Programmes.
Is Solvonis Therapeutics publicly traded?
Yes, Solvonis Therapeutics is publicly traded on LSE under the ticker symbol SVNS.
How many acquisitions has Solvonis Therapeutics made?
Solvonis Therapeutics has made 1 acquisition, including AWAKN.
What is Solvonis Therapeutics's ticker symbol?
The ticker symbol of Solvonis Therapeutics is SVNS on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.